aspartic acid has been researched along with quinidine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Antalóczy, Z | 1 |
| Kretschmer, P; Selchau, M | 1 |
| Barusco, G; Fabris, C; Fanchiotti, GL | 1 |
| Blackburn, MG; Ellis, SW; Harlow, J; Hayhurst, GP; Larsson, C; Lennard, MS; Lightfoot, T; Lim, CK; Mahling, J; Rowland-Yeo, K; Smith, G; Tucker, GT; Wolf, CR | 1 |
| KIMURA, N; WADA, T | 1 |
| Flanagan, JU; Kemp, CA; Maréchal, JD; McLaughlin, LA; Paine, MJ; Roberts, GC; Sutcliffe, MJ; Ward, CJ; Wolf, CR | 1 |
1 review(s) available for aspartic acid and quinidine
| Article | Year |
|---|---|
[Cardioactive agents. 49].
Topics: Aspartic Acid; Bufanolides; Cardanolides; Cardiac Glycosides; Digitoxin; Digoxin; Heart; Heart Diseases; Humans; Khellin; Lanatosides; Nitrites; Plants, Medicinal; Procainamide; Quinidine; Strophanthins; Sympatholytics; Sympathomimetics; Vasodilator Agents | 1970 |
1 trial(s) available for aspartic acid and quinidine
| Article | Year |
|---|---|
[Drug therapy of arrhythmia].
Topics: Adult; Arrhythmias, Cardiac; Aspartic Acid; Drug Synergism; Female; Humans; Magnesium; Male; Middle Aged; Potassium; Quinidine | 1971 |
5 other study(ies) available for aspartic acid and quinidine
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[On the mechanism of resumption of sinus rhythm in chronic atrial fibrillation. (Clinical contribution)].
Topics: Anesthesia, General; Aspartic Acid; Atrial Fibrillation; Coronary Disease; Electric Countershock; Humans; Mitral Valve Insufficiency; Mitral Valve Stenosis; Phytotherapy; Plants, Medicinal; Potassium; Quinidine; Rauwolfia | 1968 |
Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.
Topics: Alanine; Amino Acid Substitution; Aspartic Acid; Binding Sites; Catalytic Domain; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Enzyme Inhibitors; Kinetics; Ligands; Metoprolol; Mutagenesis, Site-Directed; Oxidation-Reduction; Propranolol; Quinidine; Quinine; Serine; Substrate Specificity; Yeasts | 2000 |
[USE OF ANTI-ARRHYTHMIA AGENTS].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspartic Acid; Digitalis; Digitalis Glycosides; Epinephrine; Humans; Isoproterenol; Pharmacology; Procainamide; Quinidine; Tranquilizing Agents | 1964 |
Why is quinidine an inhibitor of cytochrome P450 2D6? The role of key active-site residues in quinidine binding.
Topics: Alanine; Aspartic Acid; Binding Sites; Binding, Competitive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Escherichia coli; Glutamic Acid; Humans; Kinetics; Mass Spectrometry; Mixed Function Oxygenases; Models, Molecular; Mutation; Oxidoreductases, O-Demethylating; Protein Binding; Protein Structure, Tertiary; Quinidine; Spectrophotometry; Substrate Specificity | 2005 |